RD

Roberto De Ponti

3B FUTURE Health Ventures

Monte-Carlo, Monaco

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

Global

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Pharmaceutical Industry
Drug Delivery
R&D
Technology Transfer
Drug Development
Pharmaceutical Sciences
Pharmacology
Lifesciences
Clinical Development
GLP
Biotechnology
Business Development
Oncology
Pharmaceutics
Regulatory Affairs
Biopharmaceuticals
Pharmacovigilance
Validation
Product Development
Business Strategy

Lists including Roberto

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

Fore Biotherapeutics

Series D

Total Funding: $130M

Geneos Therapeutics

Series A

Total Funding: $17M

Roca Therapeutics

Seed

Total Funding:

Domain Therapeutics

Series A

Total Funding: $47M

Work Experience

GT
Geneos Therapeutics

2023

  • Board Observer

    2023

EL
Epsilogen Ltd

2022

  • Board Observer

    2022

3F
3B Future Health Fund I & II

2022

  • Managing Director and General Partner

    2022

i
iOnctura

2020

  • Board Observer

    2020

CV
Claris Ventures SGR SpA

2020

  • Advisor

    2020

OI
OncoResponse Inc.

2016

  • Board Member

    2016

FB
Fore Biotherapeutics

2018 - 2023

  • Board Member

    2018 - 2023

GO
GreenBone Ortho S.p.A.

2020 - 2022

  • Board Member

    2020 - 2022

HG
Helsinn Group

2008 - 2021

  • Head, Corporate New Ventures and Strategic Investments

    2016 - 2021

  • Head, Corporate Business Development

    2008 - 2015

AB
Aadi Bioscience, Inc

2017 - 2021

  • Board Observer

    2017 - 2021